Total Holdings
87
Portfolio diversification across 87 positions
IBRN
(NYSEARCA)iShares Neuroscience and Healthcare ETF
$33.31-- (--)
Loading... - Market loading
IBRN ETF Holdings: iShares Neuroscience and Healthcare ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$4.95M
Total fund assets
Expense Ratio
0.47%
Annual management fee
Fund Issuer
BlackRock
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Praxis Precision Medicines, Inc | Stock | 5.39% |
| 2 |  | Xenon Pharmaceuticals Inc. | Stock | 5.22% |
| 3 |  | Axsome Therapeutics, Inc | Stock | 5.11% |
| 4 |  | Alkermes plc | Stock | 4.73% |
| 5 |  | Biogen Inc | Stock | 4.56% |
| 6 |  | Scholar Rock Holding Corp | Stock | 4.30% |
| 7 |  | Centessa Pharmaceuticals plc | Stock | 4.18% |
| 8 |  | PTC Therapeutics, Inc. | Stock | 4.07% |
| 9 |  | Arrowhead Pharmaceuticals, Inc. | Stock | 3.95% |
| 10 |  | Neurocrine Biosciences, Inc. | Stock | 3.87% |
| 11 |  | Supernus Pharmaceuticals, Inc | Stock | 3.85% |
| 12 |  | argenx SE | Stock | 3.81% |
| 13 |  | ACADIA Pharmaceuticals Inc. | Stock | 3.77% |
| 14 |  | Catalyst Pharmaceuticals Inc | Stock | 3.75% |
| 15 |  | Denali Therapeutics Inc | Stock | 3.41% |
| 16 |  | Dianthus Therapeutics, Inc. | Stock | 3.41% |
| 17 |  | Edgewise Therapeutics Inc | Stock | 3.19% |
| 18 |  | Dyne Therapeutics, Inc. | Stock | 2.56% |
| 19 |  | Sarepta Therapeutics, Inc | Stock | 2.45% |
| 20 | C CO:HLUN.B | H Lundbeck A/S | Stock | 2.30% |
| 21 |  | AxoGen, Inc | Stock | 2.08% |
| 22 | K KRX:326030 | SK Biopharmaceuticals Co., Ltd. | Stock | 1.94% |
| 23 | S ST:BIOA.B | BioArctic AB (publ) | Stock | 1.94% |
| 24 | H HLUNB.CO | H. Lundbeck AS Ordinary Shares - Class B | Stock | 1.84% |
| 25 |  | Biohaven Pharmaceutical Holding Co Ltd | Stock | 1.71% |
| 26 |  | Capricor Therapeutics, Inc. | Stock | 1.66% |
| 27 |  | Taysha Gene Therapies, Inc | Stock | 1.41% |
| 28 | S STO:BIOA.B | BioArctic AB (publ) | Stock | 1.38% |
| 29 | S ST:DYVOX | Dynavox Group | Stock | 1.19% |
| 30 |  | Rapport Therapeutics, Inc. Common Stock | Stock | 1.09% |
| 31 | T TSE:4592 | Sanbio Company Limited | Stock | 1.07% |
| 32 |  | Integra LifeSciences Holdings Corporation | Stock | 1.04% |
| 33 |  | Bright Minds Biosciences Inc | Stock | 0.84% |
| 34 |  | Annexon Inc | Stock | 0.84% |
| 35 | H HKG:2190 | Zylox-Tonbridge Med Tech Co | Stock | 0.81% |
| 36 |  | Fulcrum Therapeutics Inc | Stock | 0.71% |
| 37 | H HKG:2172 | MicroPort NeuroTech Ltd | Stock | 0.70% |
| 38 |  | CBLL | Stock | 0.61% |
| 39 | T TSE:4588 | Oncolys Biopharma Inc | Stock | 0.61% |
| 40 |  | Prothena Corporation plc | Stock | 0.55% |
| 41 |  | Neuropace Inc | Stock | 0.52% |
| 42 | H HKG:9996 | Peijia Medical Ltd | Stock | 0.52% |
| 43 |  | REGENXBIO Inc | Stock | 0.52% |
| 44 |  | Solid Biosciences Inc | Stock | 0.51% |
| 45 |  | Anavex Life Sciences Corp | Stock | 0.48% |
| 46 |  | Benitec Biopharma Inc | Stock | 0.48% |
| 47 |  | Vanda Pharmaceuticals Inc | Stock | 0.47% |
| 48 |  | ClearPoint Neuro Inc | Stock | 0.46% |
| 49 |  | Entrada Therapeutics Inc | Stock | 0.32% |
| 50 |  | Neurogene Inc | Stock | 0.31% |
Frequently Asked Questions About iShares Neuroscience and Healthcare ETF Holdings
What are the top holdings in IBRN?
iShares Neuroscience and Healthcare ETF (IBRN) holds 87 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is IBRN's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review IBRN's holdings table to analyze concentration risk.
What is IBRN's sector allocation?
The Sector Allocation chart shows how IBRN distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does IBRN invest in?
IBRN's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is IBRN ETF?
IBRN's diversification can be assessed by reviewing its 87 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.